Global Sexually Transmitted Disease (STD ) Drug Market Insights and Forecast to 2026

Sexually Transmitted Disease (STD ) Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Sexually Transmitted Disease (STD ) Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Antibiotics

    Antiviral

    Vaccines

    Hospital

    Clinic

Regional and Country-level Analysis

The Sexually Transmitted Disease (STD ) Drug market is analysed and market size information is provided by regions (countries).

The key regions covered in the Sexually Transmitted Disease (STD ) Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.

Competitive Landscape and Sexually Transmitted Disease (STD ) Drug Market Share Analysis

Sexually Transmitted Disease (STD ) Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Sexually Transmitted Disease (STD ) Drug business, the date to enter into the Sexually Transmitted Disease (STD ) Drug market, Sexually Transmitted Disease (STD ) Drug product introduction, recent developments, etc.

The major vendors covered:

    Pfizer

    Roche

    Bayer

    Eli Lilly

    Johnson & Johnson

    Bristol-Myers Squibb

    AbbVie

    Gilead Sciences

    GlaxoSmithKline

    Merck

1.1 Sexually Transmitted Disease (STD ) Drug Product Introduction

1.2 Market Segments

1.3 Key Sexually Transmitted Disease (STD ) Drug Manufacturers Covered: Ranking by Revenue

1.4 Market by Type

1.4.1 Global Sexually Transmitted Disease (STD ) Drug Market Size Growth Rate by Type

1.4.2 Antibiotics

1.4.3 Antiviral

1.4.4 Vaccines

1.5 Market by Application

1.5.1 Global Sexually Transmitted Disease (STD ) Drug Market Size Growth Rate by Application

1.5.2 Hospital

1.5.3 Clinic

1.6 Study Objectives

1.7 Years Considered

2.1 Global Sexually Transmitted Disease (STD ) Drug Market Size, Estimates and Forecasts

2.1.1 Global Sexually Transmitted Disease (STD ) Drug Revenue 2015-2026

2.1.2 Global Sexually Transmitted Disease (STD ) Drug Sales 2015-2026

2.2 Global Sexually Transmitted Disease (STD ) Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026

2.2.1 Global Sexually Transmitted Disease (STD ) Drug Retrospective Market Scenario in Sales by Region: 2015-2020

2.2.2 Global Sexually Transmitted Disease (STD ) Drug Retrospective Market Scenario in Revenue by Region: 2015-2020

3.1 Sexually Transmitted Disease (STD ) Drug Sales by Manufacturers

3.1.1 Sexually Transmitted Disease (STD ) Drug Sales by Manufacturers (2015-2020)

3.1.2 Sexually Transmitted Disease (STD ) Drug Sales Market Share by Manufacturers (2015-2020)

3.2 Sexually Transmitted Disease (STD ) Drug Revenue by Manufacturers

3.2.1 Sexually Transmitted Disease (STD ) Drug Revenue by Manufacturers (2015-2020)

3.2.2 Sexually Transmitted Disease (STD ) Drug Revenue Share by Manufacturers (2015-2020)

3.2.3 Global Sexually Transmitted Disease (STD ) Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)

3.2.4 Global Top 10 and Top 5 Companies by Sexually Transmitted Disease (STD ) Drug Revenue in 2019

3.2.5 Global Sexually Transmitted Disease (STD ) Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

3.3 Sexually Transmitted Disease (STD ) Drug Price by Manufacturers

3.4 Sexually Transmitted Disease (STD ) Drug Manufacturing Base Distribution, Product Types

3.4.1 Sexually Transmitted Disease (STD ) Drug Manufacturers Manufacturing Base Distribution, Headquarters

3.4.2 Manufacturers Sexually Transmitted Disease (STD ) Drug Product Type

3.4.3 Date of International Manufacturers Enter into Sexually Transmitted Disease (STD ) Drug Market

3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4.1 Global Sexually Transmitted Disease (STD ) Drug Market Size by Type (2015-2020)

4.1.1 Global Sexually Transmitted Disease (STD ) Drug Sales by Type (2015-2020)

4.1.2 Global Sexually Transmitted Disease (STD ) Drug Revenue by Type (2015-2020)

4.1.3 Sexually Transmitted Disease (STD ) Drug Average Selling Price (ASP) by Type (2015-2026)

4.2 Global Sexually Transmitted Disease (STD ) Drug Market Size Forecast by Type (2021-2026)

4.2.1 Global Sexually Transmitted Disease (STD ) Drug Sales Forecast by Type (2021-2026)

4.2.2 Global Sexually Transmitted Disease (STD ) Drug Revenue Forecast by Type (2021-2026)

4.2.3 Sexually Transmitted Disease (STD ) Drug Average Selling Price (ASP) Forecast by Type (2021-2026)

4.3 Global Sexually Transmitted Disease (STD ) Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5.1 Global Sexually Transmitted Disease (STD ) Drug Market Size by Application (2015-2020)

5.1.1 Global Sexually Transmitted Disease (STD ) Drug Sales by Application (2015-2020)

5.1.2 Global Sexually Transmitted Disease (STD ) Drug Revenue by Application (2015-2020)

5.1.3 Sexually Transmitted Disease (STD ) Drug Price by Application (2015-2020)

5.2 Sexually Transmitted Disease (STD ) Drug Market Size Forecast by Application (2021-2026)

5.2.1 Global Sexually Transmitted Disease (STD ) Drug Sales Forecast by Application (2021-2026)

5.2.2 Global Sexually Transmitted Disease (STD ) Drug Revenue Forecast by Application (2021-2026)

5.2.3 Global Sexually Transmitted Disease (STD ) Drug Price Forecast by Application (2021-2026)

6.1 North America Sexually Transmitted Disease (STD ) Drug by Country

6.1.1 North America Sexually Transmitted Disease (STD ) Drug Sales by Country

6.1.2 North America Sexually Transmitted Disease (STD ) Drug Revenue by Country

6.1.3 U.S.

6.1.4 Canada

6.2 North America Sexually Transmitted Disease (STD ) Drug Market Facts & Figures by Type

6.3 North America Sexually Transmitted Disease (STD ) Drug Market Facts & Figures by Application

7.1 Europe Sexually Transmitted Disease (STD ) Drug by Country

7.1.1 Europe Sexually Transmitted Disease (STD ) Drug Sales by Country

7.1.2 Europe Sexually Transmitted Disease (STD ) Drug Revenue by Country

7.1.3 Germany

7.1.4 France

7.1.5 U.K.

7.1.6 Italy

7.1.7 Russia

7.2 Europe Sexually Transmitted Disease (STD ) Drug Market Facts & Figures by Type

7.3 Europe Sexually Transmitted Disease (STD ) Drug Market Facts & Figures by Application

8.1 Asia Pacific Sexually Transmitted Disease (STD ) Drug by Region

8.1.1 Asia Pacific Sexually Transmitted Disease (STD ) Drug Sales by Region

8.1.2 Asia Pacific Sexually Transmitted Disease (STD ) Drug Revenue by Region

8.1.3 China

8.1.4 Japan

8.1.5 South Korea

8.1.6 India

8.1.7 Australia

8.1.8 Taiwan

8.1.9 Indonesia

8.1.10 Thailand

8.1.11 Malaysia

8.1.12 Philippines

8.1.13 Vietnam

8.2 Asia Pacific Sexually Transmitted Disease (STD ) Drug Market Facts & Figures by Type

8.3 Asia Pacific Sexually Transmitted Disease (STD ) Drug Market Facts & Figures by Application

9.1 Latin America Sexually Transmitted Disease (STD ) Drug by Country

9.1.1 Latin America Sexually Transmitted Disease (STD ) Drug Sales by Country

9.1.2 Latin America Sexually Transmitted Disease (STD ) Drug Revenue by Country

9.1.3 Mexico

9.1.4 Brazil

9.1.5 Argentina

9.2 Central & South America Sexually Transmitted Disease (STD ) Drug Market Facts & Figures by Type

9.3 Central & South America Sexually Transmitted Disease (STD ) Drug Market Facts & Figures by Application

10.1 Middle East and Africa Sexually Transmitted Disease (STD ) Drug by Country

10.1.1 Middle East and Africa Sexually Transmitted Disease (STD ) Drug Sales by Country

10.1.2 Middle East and Africa Sexually Transmitted Disease (STD ) Drug Revenue by Country

10.1.3 Turkey

10.1.4 Saudi Arabia

10.1.5 UAE

10.2 Middle East and Africa Sexually Transmitted Disease (STD ) Drug Market Facts & Figures by Type

10.3 Middle East and Africa Sexually Transmitted Disease (STD ) Drug Market Facts & Figures by Application

11.1 Pfizer

11.1.1 Pfizer Corporation Information

11.1.2 Pfizer Description and Business Overview

11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)

11.1.4 Pfizer Sexually Transmitted Disease (STD ) Drug Products Offered

11.1.5 Pfizer Related Developments

11.2 Roche

11.2.1 Roche Corporation Information

11.2.2 Roche Description and Business Overview

11.2.3 Roche Sales, Revenue and Gross Margin (2015-2020)

11.2.4 Roche Sexually Transmitted Disease (STD ) Drug Products Offered

11.2.5 Roche Related Developments

11.3 Bayer

11.3.1 Bayer Corporation Information

11.3.2 Bayer Description and Business Overview

11.3.3 Bayer Sales, Revenue and Gross Margin (2015-2020)

11.3.4 Bayer Sexually Transmitted Disease (STD ) Drug Products Offered

11.3.5 Bayer Related Developments

11.4 Eli Lilly

11.4.1 Eli Lilly Corporation Information

11.4.2 Eli Lilly Description and Business Overview

11.4.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)

11.4.4 Eli Lilly Sexually Transmitted Disease (STD ) Drug Products Offered

11.4.5 Eli Lilly Related Developments

11.5 Johnson & Johnson

11.5.1 Johnson & Johnson Corporation Information

11.5.2 Johnson & Johnson Description and Business Overview

11.5.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)

11.5.4 Johnson & Johnson Sexually Transmitted Disease (STD ) Drug Products Offered

11.5.5 Johnson & Johnson Related Developments

11.6 Bristol-Myers Squibb

11.6.1 Bristol-Myers Squibb Corporation Information

11.6.2 Bristol-Myers Squibb Description and Business Overview

11.6.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)

11.6.4 Bristol-Myers Squibb Sexually Transmitted Disease (STD ) Drug Products Offered

11.6.5 Bristol-Myers Squibb Related Developments

11.7 AbbVie

11.7.1 AbbVie Corporation Information

11.7.2 AbbVie Description and Business Overview

11.7.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)

11.7.4 AbbVie Sexually Transmitted Disease (STD ) Drug Products Offered

11.7.5 AbbVie Related Developments

11.8 Gilead Sciences

11.8.1 Gilead Sciences Corporation Information

11.8.2 Gilead Sciences Description and Business Overview

11.8.3 Gilead Sciences Sales, Revenue and Gross Margin (2015-2020)

11.8.4 Gilead Sciences Sexually Transmitted Disease (STD ) Drug Products Offered

11.8.5 Gilead Sciences Related Developments

11.9 GlaxoSmithKline

11.9.1 GlaxoSmithKline Corporation Information

11.9.2 GlaxoSmithKline Description and Business Overview

11.9.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)

11.9.4 GlaxoSmithKline Sexually Transmitted Disease (STD ) Drug Products Offered

11.9.5 GlaxoSmithKline Related Developments

11.10 Merck

11.10.1 Merck Corporation Information

11.10.2 Merck Description and Business Overview

11.10.3 Merck Sales, Revenue and Gross Margin (2015-2020)

11.10.4 Merck Sexually Transmitted Disease (STD ) Drug Products Offered

11.10.5 Merck Related Developments

11.1 Pfizer

11.1.1 Pfizer Corporation Information

11.1.2 Pfizer Description and Business Overview

11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)

11.1.4 Pfizer Sexually Transmitted Disease (STD ) Drug Products Offered

11.1.5 Pfizer Related Developments

12.1 Sexually Transmitted Disease (STD ) Drug Market Estimates and Projections by Region

12.1.1 Global Sexually Transmitted Disease (STD ) Drug Sales Forecast by Regions 2021-2026

12.1.2 Global Sexually Transmitted Disease (STD ) Drug Revenue Forecast by Regions 2021-2026

12.2 North America Sexually Transmitted Disease (STD ) Drug Market Size Forecast (2021-2026)

12.2.1 North America: Sexually Transmitted Disease (STD ) Drug Sales Forecast (2021-2026)

12.2.2 North America: Sexually Transmitted Disease (STD ) Drug Revenue Forecast (2021-2026)

12.2.3 North America: Sexually Transmitted Disease (STD ) Drug Market Size Forecast by Country (2021-2026)

12.3 Europe Sexually Transmitted Disease (STD ) Drug Market Size Forecast (2021-2026)

12.3.1 Europe: Sexually Transmitted Disease (STD ) Drug Sales Forecast (2021-2026)

12.3.2 Europe: Sexually Transmitted Disease (STD ) Drug Revenue Forecast (2021-2026)

12.3.3 Europe: Sexually Transmitted Disease (STD ) Drug Market Size Forecast by Country (2021-2026)

12.4 Asia Pacific Sexually Transmitted Disease (STD ) Drug Market Size Forecast (2021-2026)

12.4.1 Asia Pacific: Sexually Transmitted Disease (STD ) Drug Sales Forecast (2021-2026)

12.4.2 Asia Pacific: Sexually Transmitted Disease (STD ) Drug Revenue Forecast (2021-2026)

12.4.3 Asia Pacific: Sexually Transmitted Disease (STD ) Drug Market Size Forecast by Region (2021-2026)

12.5 Latin America Sexually Transmitted Disease (STD ) Drug Market Size Forecast (2021-2026)

12.5.1 Latin America: Sexually Transmitted Disease (STD ) Drug Sales Forecast (2021-2026)

12.5.2 Latin America: Sexually Transmitted Disease (STD ) Drug Revenue Forecast (2021-2026)

12.5.3 Latin America: Sexually Transmitted Disease (STD ) Drug Market Size Forecast by Country (2021-2026)

12.6 Middle East and Africa Sexually Transmitted Disease (STD ) Drug Market Size Forecast (2021-2026)

12.6.1 Middle East and Africa: Sexually Transmitted Disease (STD ) Drug Sales Forecast (2021-2026)

12.6.2 Middle East and Africa: Sexually Transmitted Disease (STD ) Drug Revenue Forecast (2021-2026)

12.6.3 Middle East and Africa: Sexually Transmitted Disease (STD ) Drug Market Size Forecast by Country (2021-2026)

13.1 Market Opportunities and Drivers

13.2 Market Challenges

13.3 Market Risks/Restraints

13.4 Porter's Five Forces Analysis

13.5 Primary Interviews with Key Sexually Transmitted Disease (STD ) Drug Players (Opinion Leaders)

14.1 Value Chain Analysis

14.2 Sexually Transmitted Disease (STD ) Drug Customers

14.3 Sales Channels Analysis

14.3.1 Sales Channels

14.3.2 Distributors

16.1 Research Methodology

16.1.1 Methodology/Research Approach

16.1.2 Data Source

16.2 Author Details

16.3 Disclaimer

List of Tables

    Table 1. Sexually Transmitted Disease (STD ) Drug Market Segments

    Table 2. Ranking of Global Top Sexually Transmitted Disease (STD ) Drug Manufacturers by Revenue (US$ Million) in 2019

    Table 3. Global Sexually Transmitted Disease (STD ) Drug Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)

    Table 4. Major Manufacturers of Antibiotics

    Table 5. Major Manufacturers of Antiviral

    Table 6. Major Manufacturers of Vaccines

    Table 7. Global Sexually Transmitted Disease (STD ) Drug Market Size Growth Rate by Application 2020-2026 (K Units)

    Table 8. Global Sexually Transmitted Disease (STD ) Drug Market Size by Region (K Units) & (US$ Million): 2020 VS 2026

    Table 9. Global Sexually Transmitted Disease (STD ) Drug Sales by Regions 2015-2020 (K Units)

    Table 10. Global Sexually Transmitted Disease (STD ) Drug Sales Market Share by Regions (2015-2020)

    Table 11. Global Sexually Transmitted Disease (STD ) Drug Revenue by Regions 2015-2020 (US$ Million)

    Table 12. Global Sexually Transmitted Disease (STD ) Drug Sales by Manufacturers (2015-2020) (K Units)

    Table 13. Global Sexually Transmitted Disease (STD ) Drug Sales Share by Manufacturers (2015-2020)

    Table 14. Global Sexually Transmitted Disease (STD ) Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)

    Table 15. Global Sexually Transmitted Disease (STD ) Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sexually Transmitted Disease (STD ) Drug as of 2019)

    Table 16. Sexually Transmitted Disease (STD ) Drug Revenue by Manufacturers (2015-2020) (US$ Million)

    Table 17. Sexually Transmitted Disease (STD ) Drug Revenue Share by Manufacturers (2015-2020)

    Table 18. Key Manufacturers Sexually Transmitted Disease (STD ) Drug Price (2015-2020) (US$/Unit)

    Table 19. Sexually Transmitted Disease (STD ) Drug Manufacturers Manufacturing Base Distribution and Headquarters

    Table 20. Manufacturers Sexually Transmitted Disease (STD ) Drug Product Type

    Table 21. Date of International Manufacturers Enter into Sexually Transmitted Disease (STD ) Drug Market

    Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans

    Table 23. Global Sexually Transmitted Disease (STD ) Drug Sales by Type (2015-2020) (K Units)

    Table 24. Global Sexually Transmitted Disease (STD ) Drug Sales Share by Type (2015-2020)

    Table 25. Global Sexually Transmitted Disease (STD ) Drug Revenue by Type (2015-2020) (US$ Million)

    Table 26. Global Sexually Transmitted Disease (STD ) Drug Revenue Share by Type (2015-2020)

    Table 27. Sexually Transmitted Disease (STD ) Drug Average Selling Price (ASP) by Type 2015-2020 (US$/Unit)

    Table 28. Global Sexually Transmitted Disease (STD ) Drug Sales by Application (2015-2020) (K Units)

    Table 29. Global Sexually Transmitted Disease (STD ) Drug Sales Share by Application (2015-2020)

    Table 30. North America Sexually Transmitted Disease (STD ) Drug Sales by Country (2015-2020) (K Units)

    Table 31. North America Sexually Transmitted Disease (STD ) Drug Sales Market Share by Country (2015-2020)

    Table 32. North America Sexually Transmitted Disease (STD ) Drug Revenue by Country (2015-2020) (US$ Million)

    Table 33. North America Sexually Transmitted Disease (STD ) Drug Revenue Market Share by Country (2015-2020)

    Table 34. North America Sexually Transmitted Disease (STD ) Drug Sales by Type (2015-2020) (K Units)

    Table 35. North America Sexually Transmitted Disease (STD ) Drug Sales Market Share by Type (2015-2020)

    Table 36. North America Sexually Transmitted Disease (STD ) Drug Sales by Application (2015-2020) (K Units)

    Table 37. North America Sexually Transmitted Disease (STD ) Drug Sales Market Share by Application (2015-2020)

    Table 38. Europe Sexually Transmitted Disease (STD ) Drug Sales by Country (2015-2020) (K Units)

    Table 39. Europe Sexually Transmitted Disease (STD ) Drug Sales Market Share by Country (2015-2020)

    Table 40. Europe Sexually Transmitted Disease (STD ) Drug Revenue by Country (2015-2020) (US$ Million)

    Table 41. Europe Sexually Transmitted Disease (STD ) Drug Revenue Market Share by Country (2015-2020)

    Table 42. Europe Sexually Transmitted Disease (STD ) Drug Sales by Type (2015-2020) (K Units)

    Table 43. Europe Sexually Transmitted Disease (STD ) Drug Sales Market Share by Type (2015-2020)

    Table 44. Europe Sexually Transmitted Disease (STD ) Drug Sales by Application (2015-2020) (K Units)

    Table 45. Europe Sexually Transmitted Disease (STD ) Drug Sales Market Share by Application (2015-2020)

    Table 46. Asia Pacific Sexually Transmitted Disease (STD ) Drug Sales by Region (2015-2020) (K Units)

    Table 47. Asia Pacific Sexually Transmitted Disease (STD ) Drug Sales Market Share by Region (2015-2020)

    Table 48. Asia Pacific Sexually Transmitted Disease (STD ) Drug Revenue by Region (2015-2020) (US$ Million)

    Table 49. Asia Pacific Sexually Transmitted Disease (STD ) Drug Revenue Market Share by Region (2015-2020)

    Table 50. Asia Pacific Sexually Transmitted Disease (STD ) Drug Sales by Type (2015-2020) (K Units)

    Table 51. Asia Pacific Sexually Transmitted Disease (STD ) Drug Sales Market Share by Type (2015-2020)

    Table 52. Asia Pacific Sexually Transmitted Disease (STD ) Drug Sales by Application (2015-2020) (K Units)

    Table 53. Asia Pacific Sexually Transmitted Disease (STD ) Drug Sales Market Share by Application (2015-2020)

    Table 54. Latin America Sexually Transmitted Disease (STD ) Drug Sales by Country (2015-2020) (K Units)

    Table 55. Latin America Sexually Transmitted Disease (STD ) Drug Sales Market Share by Country (2015-2020)

    Table 56. Latin Americaa Sexually Transmitted Disease (STD ) Drug Revenue by Country (2015-2020) (US$ Million)

    Table 57. Latin America Sexually Transmitted Disease (STD ) Drug Revenue Market Share by Country (2015-2020)

    Table 58. Latin America Sexually Transmitted Disease (STD ) Drug Sales by Type (2015-2020) (K Units)

    Table 59. Latin America Sexually Transmitted Disease (STD ) Drug Sales Market Share by Type (2015-2020)

    Table 60. Latin America Sexually Transmitted Disease (STD ) Drug Sales by Application (2015-2020) (K Units)

    Table 61. Latin America Sexually Transmitted Disease (STD ) Drug Sales Market Share by Application (2015-2020)

    Table 62. Middle East and Africa Sexually Transmitted Disease (STD ) Drug Sales by Country (2015-2020) (K Units)

    Table 63. Middle East and Africa Sexually Transmitted Disease (STD ) Drug Sales Market Share by Country (2015-2020)

    Table 64. Middle East and Africa Sexually Transmitted Disease (STD ) Drug Revenue by Country (2015-2020) (US$ Million)

    Table 65. Middle East and Africa Sexually Transmitted Disease (STD ) Drug Revenue Market Share by Country (2015-2020)

    Table 66. Middle East and Africa Sexually Transmitted Disease (STD ) Drug Sales by Type (2015-2020) (K Units)

    Table 67. Middle East and Africa Sexually Transmitted Disease (STD ) Drug Sales Market Share by Type (2015-2020)

    Table 68. Middle East and Africa Sexually Transmitted Disease (STD ) Drug Sales by Application (2015-2020) (K Units)

    Table 69. Middle East and Africa Sexually Transmitted Disease (STD ) Drug Sales Market Share by Application (2015-2020)

    Table 70. Pfizer Corporation Information

    Table 71. Pfizer Description and Major Businesses

    Table 72. Pfizer Sexually Transmitted Disease (STD ) Drug Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)

    Table 73. Pfizer Product

    Table 74. Pfizer Recent Development

    Table 75. Roche Corporation Information

    Table 76. Roche Description and Major Businesses

    Table 77. Roche Sexually Transmitted Disease (STD ) Drug Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)

    Table 78. Roche Product

    Table 79. Roche Recent Development

    Table 80. Bayer Corporation Information

    Table 81. Bayer Description and Major Businesses

    Table 82. Bayer Sexually Transmitted Disease (STD ) Drug Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)

    Table 83. Bayer Product

    Table 84. Bayer Recent Development

    Table 85. Eli Lilly Corporation Information

    Table 86. Eli Lilly Description and Major Businesses

    Table 87. Eli Lilly Sexually Transmitted Disease (STD ) Drug Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)

    Table 88. Eli Lilly Product

    Table 89. Eli Lilly Recent Development

    Table 90. Johnson & Johnson Corporation Information

    Table 91. Johnson & Johnson Description and Major Businesses

    Table 92. Johnson & Johnson Sexually Transmitted Disease (STD ) Drug Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)

    Table 93. Johnson & Johnson Product

    Table 94. Johnson & Johnson Recent Development

    Table 95. Bristol-Myers Squibb Corporation Information

    Table 96. Bristol-Myers Squibb Description and Major Businesses

    Table 97. Bristol-Myers Squibb Sexually Transmitted Disease (STD ) Drug Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)

    Table 98. Bristol-Myers Squibb Product

    Table 99. Bristol-Myers Squibb Recent Development

    Table 100. AbbVie Corporation Information

    Table 101. AbbVie Description and Major Businesses

    Table 102. AbbVie Sexually Transmitted Disease (STD ) Drug Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)

    Table 103. AbbVie Product

    Table 104. AbbVie Recent Development

    Table 105. Gilead Sciences Corporation Information

    Table 106. Gilead Sciences Description and Major Businesses

    Table 107. Gilead Sciences Sexually Transmitted Disease (STD ) Drug Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)

    Table 108. Gilead Sciences Product

    Table 109. Gilead Sciences Recent Development

    Table 110. GlaxoSmithKline Corporation Information

    Table 111. GlaxoSmithKline Description and Major Businesses

    Table 112. GlaxoSmithKline Sexually Transmitted Disease (STD ) Drug Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)

    Table 113. GlaxoSmithKline Product

    Table 114. GlaxoSmithKline Recent Development

    Table 115. Merck Corporation Information

    Table 116. Merck Description and Major Businesses

    Table 117. Merck Sexually Transmitted Disease (STD ) Drug Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)

    Table 118. Merck Product

    Table 119. Merck Recent Development

    Table 120. Global Sexually Transmitted Disease (STD ) Drug Sales Forecast by Regions (2021-2026) (K Units)

    Table 121. Global Sexually Transmitted Disease (STD ) Drug Sales Market Share Forecast by Regions (2021-2026)

    Table 122. Global Sexually Transmitted Disease (STD ) Drug Revenue Forecast by Regions (2021-2026) (US$ Million)

    Table 123. Global Sexually Transmitted Disease (STD ) Drug Revenue Market Share Forecast by Regions (2021-2026)

    Table 124. North America: Sexually Transmitted Disease (STD ) Drug Sales Forecast by Country (2021-2026) (K Units)

    Table 125. North America: Sexually Transmitted Disease (STD ) Drug Revenue Forecast by Country (2021-2026) (US$ Million)

    Table 126. Europe: Sexually Transmitted Disease (STD ) Drug Sales Forecast by Country (2021-2026) (K Units)

    Table 127. Europe: Sexually Transmitted Disease (STD ) Drug Revenue Forecast by Country (2021-2026) (US$ Million)

    Table 128. Asia Pacific: Sexually Transmitted Disease (STD ) Drug Sales Forecast by Region (2021-2026) (K Units)

    Table 129. Asia Pacific: Sexually Transmitted Disease (STD ) Drug Revenue Forecast by Region (2021-2026) (US$ Million)

    Table 130. Latin America: Sexually Transmitted Disease (STD ) Drug Sales Forecast by Country (2021-2026) (K Units)

    Table 131. Latin America: Sexually Transmitted Disease (STD ) Drug Revenue Forecast by Country (2021-2026) (US$ Million)

    Table 132. Middle East and Africa: Sexually Transmitted Disease (STD ) Drug Sales Forecast by Country (2021-2026) (K Units)

    Table 133. Middle East and Africa: Sexually Transmitted Disease (STD ) Drug Revenue Forecast by Country (2021-2026) (US$ Million)

    Table 134. Key Opportunities and Drivers: Impact Analysis (2021-2026)

    Table 135. Key Challenges

    Table 136. Market Risks

    Table 137. Main Points Interviewed from Key Sexually Transmitted Disease (STD ) Drug Players

    Table 138. Sexually Transmitted Disease (STD ) Drug Customers List

    Table 139. Sexually Transmitted Disease (STD ) Drug Distributors List

    Table 140. Research Programs/Design for This Report

    Table 141. Key Data Information from Secondary Sources

    Table 142. Key Data Information from Primary Sources

List of Figures

    Figure 1. Sexually Transmitted Disease (STD ) Drug Product Picture

    Figure 2. Global Sexually Transmitted Disease (STD ) Drug Sales Market Share by Type in 2020 & 2026

    Figure 3. Antibiotics Product Picture

    Figure 4. Antiviral Product Picture

    Figure 5. Vaccines Product Picture

    Figure 6. Global Sexually Transmitted Disease (STD ) Drug Sales Market Share by Application in 2020 & 2026

    Figure 7. Hospital

    Figure 8. Clinic

    Figure 9. Sexually Transmitted Disease (STD ) Drug Report Years Considered

    Figure 10. Global Sexually Transmitted Disease (STD ) Drug Market Size 2015-2026 (US$ Million)

    Figure 11. Global Sexually Transmitted Disease (STD ) Drug Sales 2015-2026 (K Units)

    Figure 12. Global Sexually Transmitted Disease (STD ) Drug Market Size Market Share by Region: 2020 Versus 2026

    Figure 13. Global Sexually Transmitted Disease (STD ) Drug Sales Market Share by Region (2015-2020)

    Figure 14. Global Sexually Transmitted Disease (STD ) Drug Sales Market Share by Region in 2019

    Figure 15. Global Sexually Transmitted Disease (STD ) Drug Revenue Market Share by Region (2015-2020)

    Figure 16. Global Sexually Transmitted Disease (STD ) Drug Revenue Market Share by Region in 2019

    Figure 17. Global Sexually Transmitted Disease (STD ) Drug Sales Share by Manufacturer in 2019

    Figure 18. The Top 10 and 5 Players Market Share by Sexually Transmitted Disease (STD ) Drug Revenue in 2019

    Figure 19. Sexually Transmitted Disease (STD ) Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019

    Figure 20. Global Sexually Transmitted Disease (STD ) Drug Sales Market Share by Type (2015-2020)

    Figure 21. Global Sexually Transmitted Disease (STD ) Drug Sales Market Share by Type in 2019

    Figure 22. Global Sexually Transmitted Disease (STD ) Drug Revenue Market Share by Type (2015-2020)

    Figure 23. Global Sexually Transmitted Disease (STD ) Drug Revenue Market Share by Type in 2019

    Figure 24. Global Sexually Transmitted Disease (STD ) Drug Market Share by Price Range (2015-2020)

    Figure 25. Global Sexually Transmitted Disease (STD ) Drug Sales Market Share by Application (2015-2020)

    Figure 26. Global Sexually Transmitted Disease (STD ) Drug Sales Market Share by Application in 2019

    Figure 27. Global Sexually Transmitted Disease (STD ) Drug Revenue Market Share by Application (2015-2020)

    Figure 28. Global Sexually Transmitted Disease (STD ) Drug Revenue Market Share by Application in 2019

    Figure 29. North America Sexually Transmitted Disease (STD ) Drug Sales Growth Rate 2015-2020 (K Units)

    Figure 30. North America Sexually Transmitted Disease (STD ) Drug Revenue Growth Rate 2015-2020 (US$ Million)

    Figure 31. North America Sexually Transmitted Disease (STD ) Drug Sales Market Share by Country in 2019

    Figure 32. North America Sexually Transmitted Disease (STD ) Drug Revenue Market Share by Country in 2019

    Figure 33. U.S. Sexually Transmitted Disease (STD ) Drug Sales Growth Rate (2015-2020) (K Units)

    Figure 34. U.S. Sexually Transmitted Disease (STD ) Drug Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 35. Canada Sexually Transmitted Disease (STD ) Drug Sales Growth Rate (2015-2020) (K Units)

    Figure 36. Canada Sexually Transmitted Disease (STD ) Drug Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 37. North America Sexually Transmitted Disease (STD ) Drug Market Share by Type in 2019

    Figure 38. North America Sexually Transmitted Disease (STD ) Drug Market Share by Application in 2019

    Figure 39. Europe Sexually Transmitted Disease (STD ) Drug Sales Growth Rate 2015-2020 (K Units)

    Figure 40. Europe Sexually Transmitted Disease (STD ) Drug Revenue Growth Rate 2015-2020 (US$ Million)

    Figure 41. Europe Sexually Transmitted Disease (STD ) Drug Sales Market Share by Country in 2019

    Figure 42. Europe Sexually Transmitted Disease (STD ) Drug Revenue Market Share by Country in 2019

    Figure 43. Germany Sexually Transmitted Disease (STD ) Drug Sales Growth Rate (2015-2020) (K Units)

    Figure 44. Germany Sexually Transmitted Disease (STD ) Drug Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 45. France Sexually Transmitted Disease (STD ) Drug Sales Growth Rate (2015-2020) (K Units)

    Figure 46. France Sexually Transmitted Disease (STD ) Drug Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 47. U.K. Sexually Transmitted Disease (STD ) Drug Sales Growth Rate (2015-2020) (K Units)

    Figure 48. U.K. Sexually Transmitted Disease (STD ) Drug Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 49. Italy Sexually Transmitted Disease (STD ) Drug Sales Growth Rate (2015-2020) (K Units)

    Figure 50. Italy Sexually Transmitted Disease (STD ) Drug Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 51. Russia Sexually Transmitted Disease (STD ) Drug Sales Growth Rate (2015-2020) (K Units)

    Figure 52. Russia Sexually Transmitted Disease (STD ) Drug Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 53. Europe Sexually Transmitted Disease (STD ) Drug Market Share by Type in 2019

    Figure 54. Europe Sexually Transmitted Disease (STD ) Drug Market Share by Application in 2019

    Figure 55. Asia Pacific Sexually Transmitted Disease (STD ) Drug Sales Growth Rate 2015-2020 (K Units)

    Figure 56. Asia Pacific Sexually Transmitted Disease (STD ) Drug Revenue Growth Rate 2015-2020 (US$ Million)

    Figure 57. Asia Pacific Sexually Transmitted Disease (STD ) Drug Sales Market Share by Region in 2019

    Figure 58. Asia Pacific Sexually Transmitted Disease (STD ) Drug Revenue Market Share by Region in 2019

    Figure 59. China Sexually Transmitted Disease (STD ) Drug Sales Growth Rate (2015-2020) (K Units)

    Figure 60. China Sexually Transmitted Disease (STD ) Drug Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 61. Japan Sexually Transmitted Disease (STD ) Drug Sales Growth Rate (2015-2020) (K Units)

    Figure 62. Japan Sexually Transmitted Disease (STD ) Drug Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 63. South Korea Sexually Transmitted Disease (STD ) Drug Sales Growth Rate (2015-2020) (K Units)

    Figure 64. South Korea Sexually Transmitted Disease (STD ) Drug Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 65. India Sexually Transmitted Disease (STD ) Drug Sales Growth Rate (2015-2020) (K Units)

    Figure 66. India Sexually Transmitted Disease (STD ) Drug Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 67. Australia Sexually Transmitted Disease (STD ) Drug Sales Growth Rate (2015-2020) (K Units)

    Figure 68. Australia Sexually Transmitted Disease (STD ) Drug Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 69. Taiwan Sexually Transmitted Disease (STD ) Drug Sales Growth Rate (2015-2020) (K Units)

    Figure 70. Taiwan Sexually Transmitted Disease (STD ) Drug Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 71. Indonesia Sexually Transmitted Disease (STD ) Drug Sales Growth Rate (2015-2020) (K Units)

    Figure 72. Indonesia Sexually Transmitted Disease (STD ) Drug Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 73. Thailand Sexually Transmitted Disease (STD ) Drug Sales Growth Rate (2015-2020) (K Units)

    Figure 74. Thailand Sexually Transmitted Disease (STD ) Drug Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 75. Malaysia Sexually Transmitted Disease (STD ) Drug Sales Growth Rate (2015-2020) (K Units)

    Figure 76. Malaysia Sexually Transmitted Disease (STD ) Drug Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 77. Philippines Sexually Transmitted Disease (STD ) Drug Sales Growth Rate (2015-2020) (K Units)

    Figure 78. Philippines Sexually Transmitted Disease (STD ) Drug Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 79. Vietnam Sexually Transmitted Disease (STD ) Drug Sales Growth Rate (2015-2020) (K Units)

    Figure 80. Vietnam Sexually Transmitted Disease (STD ) Drug Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 81. Asia Pacific Sexually Transmitted Disease (STD ) Drug Market Share by Type in 2019

    Figure 82. Asia Pacific Sexually Transmitted Disease (STD ) Drug Market Share by Application in 2019

    Figure 83. Latin America Sexually Transmitted Disease (STD ) Drug Sales Growth Rate 2015-2020 (K Units)

    Figure 84. Latin America Sexually Transmitted Disease (STD ) Drug Revenue Growth Rate 2015-2020 (US$ Million)

    Figure 85. Latin America Sexually Transmitted Disease (STD ) Drug Sales Market Share by Country in 2019

    Figure 86. Latin America Sexually Transmitted Disease (STD ) Drug Revenue Market Share by Country in 2019

    Figure 87. Mexico Sexually Transmitted Disease (STD ) Drug Sales Growth Rate (2015-2020) (K Units)

    Figure 88. Mexico Sexually Transmitted Disease (STD ) Drug Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 89. Brazil Sexually Transmitted Disease (STD ) Drug Sales Growth Rate (2015-2020) (K Units)

    Figure 90. Brazil Sexually Transmitted Disease (STD ) Drug Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 91. Argentina Sexually Transmitted Disease (STD ) Drug Sales Growth Rate (2015-2020) (K Units)

    Figure 92. Argentina Sexually Transmitted Disease (STD ) Drug Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 93. Latin America Sexually Transmitted Disease (STD ) Drug Market Share by Type in 2019

    Figure 94. Latin America Sexually Transmitted Disease (STD ) Drug Market Share by Application in 2019

    Figure 95. Middle East and Africa Sexually Transmitted Disease (STD ) Drug Sales Growth Rate 2015-2020 (K Units)

    Figure 96. Middle East and Africa Sexually Transmitted Disease (STD ) Drug Revenue Growth Rate 2015-2020 (US$ Million)

    Figure 97. Middle East and Africa Sexually Transmitted Disease (STD ) Drug Sales Market Share by Country in 2019

    Figure 98. Middle East and Africa Sexually Transmitted Disease (STD ) Drug Revenue Market Share by Country in 2019

    Figure 99. Turkey Sexually Transmitted Disease (STD ) Drug Sales Growth Rate (2015-2020) (K Units)

    Figure 100. Turkey Sexually Transmitted Disease (STD ) Drug Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 101. Saudi Arabia Sexually Transmitted Disease (STD ) Drug Sales Growth Rate (2015-2020) (K Units)

    Figure 102. Saudi Arabia Sexually Transmitted Disease (STD ) Drug Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 103. UAE Sexually Transmitted Disease (STD ) Drug Sales Growth Rate (2015-2020) (K Units)

    Figure 104. UAE Sexually Transmitted Disease (STD ) Drug Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 105. Middle East and Africa Sexually Transmitted Disease (STD ) Drug Market Share by Type in 2019

    Figure 106. Middle East and Africa Sexually Transmitted Disease (STD ) Drug Market Share by Application in 2019

    Figure 107. North America Sexually Transmitted Disease (STD ) Drug Sales Growth Rate Forecast (2021-2026) (K Units)

    Figure 108. North America Sexually Transmitted Disease (STD ) Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)

    Figure 109. Europe Sexually Transmitted Disease (STD ) Drug Sales Growth Rate Forecast (2021-2026) (K Units)

    Figure 110. Europe Sexually Transmitted Disease (STD ) Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)

    Figure 111. Asia Pacific Sexually Transmitted Disease (STD ) Drug Sales Growth Rate Forecast (2021-2026) (K Units)

    Figure 112. Asia Pacific Sexually Transmitted Disease (STD ) Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)

    Figure 113. Latin America Sexually Transmitted Disease (STD ) Drug Sales Growth Rate Forecast (2021-2026) (K Units)

    Figure 114. Latin America Sexually Transmitted Disease (STD ) Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)

    Figure 115. Middle East and Africa Sexually Transmitted Disease (STD ) Drug Sales Growth Rate Forecast (2021-2026) (K Units)

    Figure 116. Middle East and Africa Sexually Transmitted Disease (STD ) Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)

    Figure 117. Porter's Five Forces Analysis

    Figure 118. Channels of Distribution

    Figure 119. Distributors Profiles

    Figure 120. Bottom-up and Top-down Approaches for This Report

    Figure 121. Data Triangulation

    Figure 122. Key Executives Interviewed